Resistance of Candida parapsilosis to drugs

Biol Cell. 1986;58(1):71-8. doi: 10.1111/j.1768-322x.1986.tb00489.x.

Abstract

Several strains of Candida parapsilosis, isolated independently in our laboratory, had their resistance compared to a series of inhibitors which act either at the level of mitochondrial ribosomes (chloramphenicol, erythromycin, paromomycin) or at the level of mitochondrial respiration and oxidative phosphorylation (oligomycin, antimycin A, diuron, carbonylcyanide m-chlorophenylhydrazone). Cells were grown on glycerol media supplemented with one of these inhibitors, and it was demonstrated that the resistance of these yeasts to a large spectrum of antibiotics was due to several features: a resistance to oligomycin was found at the permeation level; the resistance to the other drugs was correlated to the relative insensitivity of cytochrome biosynthesis to the drugs; the cells developed, at the same time, two types of alternative pathways: the one branched at the ubiquinone level which drove electrons from Krebs cycle substrates to oxygen, and the other, antimycin A-insensitive but inhibited by amytal, salicylhydroxamic acid and high cyanide concentrations. This secondary mitochondrial pathway, driving reducing equivalents from cytoplasmic NADH to cytochrome c and then to cytochrome aa3 or to alternate oxidase, allowed the growth of Candida parapsilosis on a non fermentescible medium, supplemented with these drugs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimycin A / pharmacology
  • Candida / drug effects*
  • Candida / genetics
  • Chloramphenicol / pharmacology
  • Cytochromes / metabolism
  • DNA, Mitochondrial / genetics
  • Diuron / pharmacology
  • Drug Resistance, Microbial
  • Erythromycin / pharmacology
  • Fungal Proteins / genetics
  • Oxygen Consumption / drug effects
  • Species Specificity

Substances

  • Cytochromes
  • DNA, Mitochondrial
  • Fungal Proteins
  • Erythromycin
  • Antimycin A
  • Chloramphenicol
  • Diuron